Moderna Therapeutics Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Moderna Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1997
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:108
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Moderna Therapeutics Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Moderna Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Moderna Therapeutics Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Moderna Therapeutics Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Moderna Therapeutics Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Moderna Therapeutics Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Moderna Therapeutics Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Moderna Therapeutics Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Moderna Therapeutics Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
PARTNERSHIP 8
Partnership – Overview 8
Partnership – Deal reports 9
CAPITAL RAISING 42
Capital Raising – Overview 42
Capital Raising – Deal reports 43
PRIVATE EQUITY & OWNERSHIP 84
Private Equity and Ownership – Overview 84
Private Equity and Ownership – Deal reports 85
APPENDIX 98
Contact Us 98
About MarketLine Financial Deals Database 98
Deal Definition and Methodology 100
About MarketLine 107

List of Tables
Table 1: Moderna Therapeutics Inc partnership volume and value trend (2014-YTD2018)
Table 2: Moderna Therapeutics Inc partnership trend by key deal type (2014-YTD2018)
Table 3: Moderna Therapeutics Inc capital raising volume and value trend (2014-YTD2018)
Table 4: Moderna Therapeutics Inc capital raising by deal type (2014-YTD2018)
Table 5: Moderna Therapeutics Inc private equity and ownership volume and value trend (2014-YTD2018)
Table 6: Moderna Therapeutics Inc private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Moderna Therapeutics Inc partnership volume and value trend (2014-YTD2018)
Figure 2: Moderna Therapeutics Inc partnership trend by key deal type (2014-YTD2018)
Figure 3: Moderna Therapeutics Inc capital raising volume and value trend (2014-YTD2018)
Figure 4: Moderna Therapeutics Inc capital raising by deal type (2014-YTD2018)
Figure 5: Moderna Therapeutics Inc private equity and ownership volume and value trend (2014-YTD2018)
Figure 6: Moderna Therapeutics Inc private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Moderna Therapeutics Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Mitsubishi Chemical Holdings Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Mississippi Power Co-エネルギー分野:企業M&A・提携分析
    Summary Mississippi Power Company (Mississippi Power), a subsidiary of Southern Company, is a vertically integrated electric utility which generates, procures, transmits, distributes, and sells energy. It produces power from coal and natural gas sources. Mississippi Power owns and operates fossil st …
  • HHV Solar Technologies Ltd:電力:M&Aディール及び事業提携情報
    Summary HHV Solar Technologies Ltd (HHV Solar), a subsidiary of Swelect Energy Systems Ltd, is a renewable energy company that manufactures and markets silicon photovoltaic solar modules. The company's modules include monocrystalline solar photovoltaic modules, multi-crystalline solar photovoltaic m …
  • Agilent Technologies Inc (A):医療機器:M&Aディール及び事業提携情報
    Summary Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The …
  • Pharma Mar SA (PHM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • Resources Connection Inc (RECN):企業の財務・戦略的SWOT分析
    Summary Resources Connection Inc (Resources Connection) operates as a consultancy firm that offers consulting and business initiative support services. The firm offers services such as change management, finance and accounting services, merger and acquisition transaction services, program and projec …
  • Zeus Co., Ltd. (079370):企業の財務・戦略的SWOT分析
    Zeus Co., Ltd. (079370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Dassault Systemes SA (DSY):医療機器:M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • Epicor Software Corp:企業の戦略的SWOT分析
    Epicor Software Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Incyte Corp (INCY):企業の財務・戦略的SWOT分析
    Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Omnova Solutions Inc (OMN):企業の財務・戦略的SWOT分析
    Omnova Solutions Inc (OMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Svenska Petroleum Exploration AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Svenska Petroleum Exploration AB (Svenska Petroleum), a subsidiary of Petroswede AB is an oil and gas company that offers offshore oil exploration and production. The company operates 3D Sendji data and acquisition of new 3D data in Kaba area to explore for the pre-salt. It has oil and gas p …
  • iMedX Inc-医療機器分野:企業M&A・提携分析
    Summary iMedX Inc (iMedX) is a provider of medical document management and health information solutions. The company offers transcription services and coding services. It provides iMedX Express web based platforms and iMedX Mobile with DocAssist applications. iMedX’s transcription services comprise …
  • Meiji Holdings Co, Ltd.:企業の戦略・SWOT・財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Krka dd Novo Mesto (KRKG):企業の財務・戦略的SWOT分析
    Summary Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and meta …
  • Atea ASA (ATEA):企業の財務・戦略的SWOT分析
    Atea ASA (ATEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • LGC Ltd-製薬・医療分野:企業M&A・提携分析
    Summary LGC Ltd (LGC) formerly LGC (Teddington) Limited, is a life sciences measurement and testing company which offers reference materials, genomics solutions and analytical testing products and services. Its products portfolio includes AutoGen, DNA extraction instrumentation, DNA extraction kits, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆